These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. A single institution, randomized, prospective trial of cyclosporin versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients. Najarian JS; Fryd DS; Strand M; Canafax DM; Ascher NL; Payne WD; Simmons RL; Sutherland DE Ann Surg; 1985 Feb; 201(2):142-57. PubMed ID: 3882063 [TBL] [Abstract][Full Text] [Related]
29. A controlled trial antilymphocyte globulin therapy (ALG) in man. Sheil AG; Mears D; Kelly GE; Stewart JH; Johnson JR; Tiller D; Gallery ED; Duggin GG Transplant Proc; 1972 Dec; 4(4):501-5. PubMed ID: 4118965 [No Abstract] [Full Text] [Related]
30. The intravenous administration of equine antilymphocytic globulin in renal transplant recipients and the detection of circulating antibodies to equine globulin. James K; Pullar DM; Morton JB; Dalton RG; Nolan B; Woodruff MF Clin Exp Immunol; 1971 Apr; 8(4):529-42. PubMed ID: 4995934 [TBL] [Abstract][Full Text] [Related]
31. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection. Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569 [TBL] [Abstract][Full Text] [Related]
32. Early and late effects of two immunosuppressive drug protocols on recipients of renal allografts: results of the Minnesota randomized trial comparing cyclosporine versus antilymphocyte globulin-azathioprine. Canafax DM; Simmons RL; Sutherland DE; Fryd DS; Strand MH; Ascher NL; Payne WD; Najarian JS Transplant Proc; 1986 Apr; 18(2 Suppl 1):192-6. PubMed ID: 3515687 [No Abstract] [Full Text] [Related]
33. Quadruple drug therapy prevents graft loss from acute rejection without increasing mortality. Light JA; Aquino A; Ali A; Rodriguez R; Ali S Transplant Proc; 1987 Feb; 19(1 Pt 3):1927-30. PubMed ID: 3547897 [No Abstract] [Full Text] [Related]
34. The monkey skin graft model as an assay of human antilymphocyte globulin. Kobayashi K; Hricko GM; Reisner GS; Levin L; Latham WC; Lukl P; Busch GJ; Birtch AG Transplantation; 1972 Dec; 14(6):698-704. PubMed ID: 4630076 [No Abstract] [Full Text] [Related]
35. Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation. Clark G; Walsh G; Deshpande P; Koffman G Nephrol Dial Transplant; 2002 Jul; 17(7):1304-9. PubMed ID: 12105256 [TBL] [Abstract][Full Text] [Related]
36. Studies on goat anti-CBA thymocyte globulin: the immunosuppressive activity of anti-lymphocyte globulin in mice tolerant to, or sensitized to, goat gamma-globulin. Fahey KJ Aust J Exp Biol Med Sci; 1973 Aug; 51(4):501-11. PubMed ID: 4128656 [No Abstract] [Full Text] [Related]
37. The selective use of antilymphocyte serum for cyclosporine treated patients with renal allograft dysfunction. Delmonico FL; Auchincloss H; Rubin RH; Russell PS; Tolkoff-Rubin N; Fang LT; Cosimi AB Ann Surg; 1987 Nov; 206(5):649-54. PubMed ID: 3314751 [TBL] [Abstract][Full Text] [Related]
38. Allergic reactions to a horse globulin therapy and their prevention by induction of immunological tolerance. Ring J; Seifert J; Lob G; Hopf U; Land W; Brendel W Allergol Immunopathol (Madr); 1974; 2(2):93-8. PubMed ID: 4211785 [No Abstract] [Full Text] [Related]
39. [Antilymphocytic globulin (GAL). Clinical use in 18 renal transplantation patients]. Galvão MM; Mendes NF; Ramos OL; Sabbaga E Rev Bras Pesqui Med Biol; 1972; 5(5):251-8. PubMed ID: 4573042 [No Abstract] [Full Text] [Related]
40. Transplantation of the canine hind limb. Surgical technique and methods of immunosuppression for allotransplantation. A preliminary report. Lance EM; Inglis AE; Figarola F; Veith FJ J Bone Joint Surg Am; 1971 Sep; 53(6):1137-49. PubMed ID: 4937289 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]